FDA Failed Public on Vioxx -- Scientist
5525
The U.S. Food and Drug  Administration failed to protect the public from Merck & Co.  Inc.'s MRK.N now-withdrawn painkiller Vioxx and is incapable  of guarding America from dangerous drugs, a veteran FDA  researcher told Congress on Thursday.
10518
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency&#39;s monitoring of the safety of prescription
596898
Two US regulators defended the Food and Drug Administration's handling of the withdrawn painkiller Vioxx, disputing the contention of heart researcher Dr. Eric Topol that the agency could have forced Merck &amp; Co. to do more safety testing.
74223
Description: NPR&#39;s Scott Simon talks with a former commissioner of the Food and Drug Administration, Dr. David Kessler, about the FDA&#39;s complications with the arthritis drug Vioxx and other drugs, and the process by which drugs are approved.
644655
The Food and Drug Administration ignored danger signals from its own scientists about Merck and Co. Inc.'s Vioxx painkiller, Sen. Charles Grassley told a hearing Thursday into the drug's withdrawal in September.
339259
Just days before a medical journal was to publish a Food and Drug Administration-sponsored study that raised concerns about the safety of the arthritis drug Vioxx, an FDA official
615863
Merck failed to warn doctors about the risks of its painkiller Vioxx and must pay a retired FBI agent $50 million to compensate for the heart attack he suffered after taking the drug, a federal jury found Thursday.
66928
CLEVELAND -- A doctor with the Cleveland Clinic is calling for a congressional investigation into whether the makers of Vioxx ignored signs it could cause heart problems.
95505
The recent Vioxx withdrawal and  testimony from an FDA insider accusing the agency of failing to  protect public health are fueling such heightened concern over  drug safety that valuable medicines could be kept from  patients, doctors said on Friday.
161932
The problems with Vioxx, taken off the market last week, raise questions about the Food and Drug Administration's safety review process. Observers say longer clinical trials should be required.
99609
Two-thirds of Food and Drug Administration scientists surveyed two years ago lacked confidence that the FDA adequately monitors the safety of prescription drugs, a report released Thursday shows.
463381
A U.S. Food and Drug Administration  reviewer who criticized the agency's handling of Merck & Co.  Inc.'s now-withdrawn Vioxx painkiller may be forced to another  position at the agency, a lawyer for the scientist said on  Monday.
323949
Pharmaceutical giant Merck &amp; Co Inc. had evidence by 2000 that its painkiller Vioxx, which was pulled off the market on Sept. 30, was not safe, a heart specialist told CBS News program &quot;60 Minutes&quot; on Sunday.
328455
One of the first researchers to link the popular prescription painkillers Vioxx and Celebrex to heart problems blamed aggressive advertising for escalating public health risks and called for enabling the government to require better clinical trials to prevent future drug disasters.
173007
The Food and Drug Administration told Merck &amp; Co. that it requires further safety and efficacy data before it will approve its successor drug to now defunct pain reliever Vioxx, the pharmaceutical maker announced Friday.
201176
A drug safety expert says his invitation to participate in a meeting on the risks of arthritis drugs like Vioxx and Bextra has been rescinded by government officials because he publicly expressed concerns about the medications.
704207
Those on Vioxx were 2.7 times likelier to have a problem, but an expert questions the safety of the entire class of painkillers. By Amanda Gardner.